Institutional Ownership Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO). We have compiled data on the 236 institutions that hold shares in the stock, with a total of 60.1 Million shares, which have been reported (via 13F filing form) to have a value of $1.79 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Farallon Capital Management LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
5,700,466
shares
|
$170 Million
0.96% of portfolio
|
Q1 2025
Added 0.46%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
5,604,591
shares
|
$167 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.47%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,859,002
shares
|
$145 Million
0.0% of portfolio
|
Q2 2024
Added 4.31%
|
|
Bellevue Group Ag
Kuesnacht, V8 |
May 14, 2025 Q1 2025 |
3,515,150
shares
|
$105 Million
2.39% of portfolio
|
Q4 2024
Reduced 5.91%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
2,449,479
shares
|
$73.1 Million
0.0% of portfolio
|
Q1 2025
Added 13.81%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
2,301,353
shares
|
$68.7 Million
0.01% of portfolio
|
Q1 2025
Reduced 5.04%
|
|
Erste Asset Management Gmb H
Vienna, C4 |
May 14, 2025 Q1 2025 |
2,229,900
shares
|
$66.5 Million
0.84% of portfolio
|
Q1 2025
Added 10.95%
|
|
Commodore Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
2,185,000
shares
|
$65.2 Million
6.27% of portfolio
|
Q1 2025
New holding
|
|
Armistice Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
2,048,000
shares
|
$61.1 Million
0.91% of portfolio
|
Q1 2025
Reduced 9.55%
|
|
Macquarie Group LTD
Australia, C3 |
May 15, 2025 Q1 2025 |
1,850,544
shares
|
$55.2 Million
0.07% of portfolio
|
Q1 2025
Added 9.83%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
1,394,581
shares
|
$41.6 Million
0.0% of portfolio
|
Q1 2025
Added 3.33%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
1,262,073
shares
|
$37.7 Million
0.01% of portfolio
|
Q1 2025
Reduced 5.04%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
1,135,592
shares
|
$33.9 Million
0.0% of portfolio
|
Q1 2025
Added 180.46%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
1,069,854
shares
|
$31.9 Million
1.97% of portfolio
|
Q1 2025
Added 0.01%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,049,360
shares
|
$31.3 Million
0.0% of portfolio
|
Q1 2025
Added 3.35%
|
|
Bnp Paribas Asset Management Holding S.A.
|
May 13, 2025 Q1 2025 |
1,025,719
shares
|
$30.6 Million
0.08% of portfolio
|
Q1 2025
Added 8.87%
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2025 Q1 2025 |
1,002,036
shares
|
$29.9 Million
0.2% of portfolio
|
Q1 2025
Added 59.81%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
May 14, 2025 Q1 2025 |
959,339
shares
|
$28.6 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.14%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
928,970
shares
|
$27.7 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.67%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
882,402
shares
|
$26.3 Million
0.03% of portfolio
|
Q2 2023
Added 26.77%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
863,499
shares
|
$25.8 Million
0.0% of portfolio
|
Q1 2025
Reduced 39.77%
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
May 15, 2025 Q1 2025 |
827,623
shares
|
$24.7 Million
0.44% of portfolio
|
Q1 2025
Reduced 9.79%
|
|
Gw&K Investment Management, LLC
Boston, MA |
May 05, 2025 Q1 2025 |
817,526
shares
|
$24.4 Million
0.22% of portfolio
|
Q1 2025
Added 19.62%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
743,000
shares
|
$22.2 Million
0.04% of portfolio
|
Q1 2025
Added 145.21%
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
658,652
shares
|
$19.7 Million
0.0% of portfolio
|
Q1 2025
Added 16.13%
|